LungArchives
Advances in antibody-drug conjugate-based combination therapy strategies for non-small cell lung cancer
Lung 1 min.
Lung
1 min.
Published on 28/07/2026 |
Original article (Full-text)
| Yunqi
Mi
et al. | Expert opinion on biological therapy 2026; 26(7): 677-691
Non-small cell lung cancer (NSCLC) continues to be one of the leading causes of cancer death worldwide. Although targeted therapies and immune checkpoint inhibitors have meaningfully improved outcomes for some patients, many still lack targetable mutations or quickly develop resistance. Antibody-drug...
SXRNSCLC-PRSP software to predict prognostic risk and survival in patients with resected T1-3N0-2M0 non-small cell lung cancer in Shanxi Province China
Lung 1 min.
Lung
1 min.
Published on 21/07/2026 |
Original article (Full-text)
| Zhang, Yunkui et al. | Journal of Cardiothoracic Surgery. Volume 21(1).
To develop SXRNSCLC-PRSP software which can predict the prognostic risk and survival of resected TNM (according to the 9th AJCC/UICC TNM stage of lung cancer) non-small cell lung cancer (NSCLC) patients in Shanxi Province China more comprehensively, accurately and conveniently, and provide reference...
